Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Ake Nilsson.
Nilsson
Ake
A
Division of Medicine, Department of Clinical Sciences, Lund University Hospital, Lund, Sweden.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006801:Humans; D019804:Mesalamine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010349:Patient Compliance
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003692:Delayed-Action Preparations; D019804:Mesalamine